NDC 70518-0597-2 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0597
- Requested NDC
- 70518-0597-2
- Package NDCs from labels
- 70518-0597-0, 70518-0597-2, 70518-0597-1, 70518-0597-3
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide Tablets, USP Rx only | REMEDYREPACK INC. | 2024-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | St Marys Medical Park Pharmacy | e7b68ea6-4fc8-441a-9640-1ccd3a482d8e | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 2ec371a5-18ba-4ce2-9725-7f99bb73454a | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 1d6ea4b4-1e3c-4f3f-989c-1a3a3c0da6bd | 2026-03-05 | Warnings | ANDA083177 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Legacy Pharmaceutical Packaging, LLC | 6d729ec5-7311-4534-9999-9d6fa4f3ba2f | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d838e918-2463-79f6-e053-2a95a90a948d | 2026-03-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 9271a2d7-be94-4e38-9f71-41e8d55e10bc | 2026-03-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lotensin HCT | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Validus Pharmaceuticals LLC | 94c4536f-e28e-48b1-8336-b3939917e99d | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| benazepril hydrochloride and hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | 3f6e6da8-6da3-47c5-a151-e6fd7206890e | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | bdd4348d-928d-ef0b-e053-2a95a90aadb4 | 2026-02-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 7d4ee5ec-5b68-453b-8d6e-214457a58159 | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 62e8c093-cd8e-4342-aadb-209c7e6699c8 | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Apotex Corp. | bd6c3495-ec70-908b-482a-a979506659e9 | 2026-02-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | dc9512cf-db66-40e9-afcb-1d6a722772e8 | 2026-02-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Diovan HCT | VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | d76a0419-05ee-437e-884c-65807aea9569 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 9fe534cd-cf5f-64b4-e053-2995a90a926e | 2026-02-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 5ec290f4-bf21-4c5b-a576-8eb2bd6bd379 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals Inc | 911a18c1-120a-46b3-b7a8-25eb37843473 | 2026-02-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Prasco Laboratories | 9d350fa2-d568-4970-a7a5-d128ff5d0a2f | 2026-02-10 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 96838fd0-ad87-4b45-b2c0-efdd1d2f3d1e | 2026-02-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 088cb67f-3eaa-4e78-9fbe-ad2d6b7c5707 | 2026-02-06 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.